Pharmacological reactivation of p53 as a strategy to treat cancer
J Zawacka‐Pankau… - Journal of internal …, 2015 - Wiley Online Library
It has been confirmed through studies using the technique of unbiased sequencing that the
TP 53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
TP 53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
Pharmacological reactivation of p53 as a strategy to treat cancer.
J Zawacka‐Pankau… - Journal of Internal …, 2015 - search.ebscohost.com
It has been confirmed through studies using the technique of unbiased sequencing that the
TP53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
TP53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
Pharmacological reactivation of p53 as a strategy to treat cancer
J Zawacka-Pankau, G Selivanova - Journal of Internal Medicine, 2015 - dialnet.unirioja.es
It has been confirmed through studies using the technique of unbiased sequencing that the
TP53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
TP53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
[PDF][PDF] Pharmacological reactivation of p53 as a strategy to treat cancer
J Zawacka-Pankau, G Selivanova - Journal of Internal Medicine, 2015 - researchgate.net
It has been confirmed through studies using the technique of unbiased sequencing that the
TP53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
TP53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
[引用][C] Pharmacological reactivation of p53 as a strategy to treat cancer
J Zawacka-Pankau, G Selivanova - Journal of Internal Medicine, 2015 - elibrary.ru
Pharmacological reactivation of p53 as a strategy to treat cancer
J Zawacka‐Pankau, G Selivanova - Journal of Internal Medicine, 2015 - infona.pl
It has been confirmed through studies using the technique of unbiased sequencing that the
TP 53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
TP 53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
Pharmacological reactivation of p53 as a strategy to treat cancer
J Zawacka-Pankau… - Journal of internal …, 2015 - pubmed.ncbi.nlm.nih.gov
It has been confirmed through studies using the technique of unbiased sequencing that the
TP53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
TP53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
Pharmacological reactivation of p53 as a strategy to treat cancer.
J Zawacka-Pankau, G Selivanova - Journal of Internal Medicine, 2015 - europepmc.org
It has been confirmed through studies using the technique of unbiased sequencing that the
TP53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …
TP53 tumour suppressor is the most frequently inactivated gene in cancer. This finding …